Leukocytapheresis (LCAP) for management of fulminant ulcerative colitis with toxic megacolon

Digestive Diseases and Sciences

Volumn 50, Issue 4, 2005, Pages 767-773

  Sawada, Koji ^a,b,d   Egashira, Akimitsu ^a,c   Ohnishi, Kunio ^a   Fukunaga, Ken ^a   Kusaka, Takeshi ^a   Shimoyama, Takashi ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b Fujimoto Hospital Medicine   (Japan)

^c Egashira Clinic   (Japan)

^d Fujimoto Hospital Medicine   (Japan)

Author keywords

Bacterial translocation; Inflammatory bowel disease; Leukocyte apheresis; Toxic megacolon; Ulcerative colitis

Indexed keywords

ANTIBIOTIC AGENT; HYDROCORTISONE; IMMUNOGLOBULIN; SALAZOSULFAPYRIDINE; STEROID;

ADULT; APHERESIS; ARTICLE; CLINICAL ARTICLE; COLON RESECTION; HUMAN; LEUKAPHERESIS; MALE; PRIORITY JOURNAL; REMISSION; SAFETY; SCORING SYSTEM; SYMPTOM; TOXIC MEGACOLON; TREATMENT OUTCOME; ULCERATIVE COLITIS;

ADULT; COLECTOMY; COLITIS, ULCERATIVE; HUMANS; LEUKAPHERESIS; MALE; MEGACOLON, TOXIC; MIDDLE AGED; TREATMENT OUTCOME;

EID: 17644409389     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-005-2571-3     Document Type: Article

References (37)

1. Gan SI, Beck PL: A new look at toxic megacolon: an update and review of incidence, etiology, pathogenesis, and management. Am J Gastroenterol 98:2363-2371, 2003
2. Sheth SG, LaMont JT: Toxic megacolon. Lancet 351:509-513, 1998
3. LaMont JT, Kandel GP: Toxic megacolon in ulcerative colitis. Early diagnosis and management. Hosp Pract (Off Ed) 1986:21
4. Panos MZ, Wood MJ, Asquith P: Toxic megacolon: the knee-elbow position relieves bowel distension. Gut 34:1726-1727, 1993
5. Present DH, Wolfson D, Gelernt IM, et al.: Medical decompression of toxic megacolon by "rolling." A new technique of decompression with favorable long-term follow-up. J Clin Gastroenterol 10:485-490, 1988
6. Riedler L, Wohlgenannt D, Stoss F, et al.: Endoscopic decompression in "toxic megacolon." Surg Endosc 3:51-53, 1989
7. Welfare MR, Barton JR, Cobden I: Hyperbaric oxygen for toxic megacolon. Lancet 353:70-71, 1999
8. Momoshima S, Kohda E, Hiramatsu K, Asakura H: Infra-arterial prednisolone infusion therapy in ulcerative colitis. AJR 145:1057-1060, 1985
9. Truelove SC, Marks CG: Toxic megacolon. Part I: Pathogenesis, diagnosis and treatment. Clin Gastroenterol 10:107-117, 1981
10. Actis GC, Ottobrelli A, Fera A, et al.: Continuously infused cyclosporine at low dose is sufficient to avoid emergency colectomy in acute attacks of ulcerative colitis without the need for high-dose steroids. J Clin Gastroenterol 17:10-13, 1993
11. Pascu M, Muller AR, Wiedenmann B, Dignass AU: Rescue therapy with tacrolimus in a patient with toxic megacolon. Int J Colorectal Dis 18:271-275, 2003
12. Hartong WA, Arvanitakis C, Skibba RM, Klotz AP: Treatment of toxic megacolon. A comparative review of 29 patients. Am J Dig Dis 22:195-200, 1977
13. Grieco MB, Bordan DL, Geiss AC, Beil AR Jr: Toxic megacolon complicating Crohn's colitis. Ann Surg 191:75-80, 1980
14. Sawada K, Ohnishi K, Fukui S, et al.: Leukocytapheresis therapy, performed with leukocyte removal filter, for inflammatory bowel disease. J Gastroenterol 30:322-329, 1995
15. Sawada K, Ohnishi K, Kosaka T, et al.: Leukocytapheresis with leukocyte removal filter as new therapy for ulcerative colitis. Ther Apheresis 1:207-211, 1997
16. Sawada K, Muto T, Shimoyama T, et al.: Multicenter randomized controlled trial for the treatment of ulcerative colitis with a leukocytapheresis column. Cur Pharm Design 9:307-321, 2003
17. Sawada K: Leukocytapheresis as an adjunct to conventional medication for inflammatory bowel disease. Dis Colon Rectum 46:S66-S77, 2003
18. Shibata H, Kuriyama T, Yamawaki N: Cellsorba. Ther Apher Dial 7:44-47, 2003
19. Aoyama T, Ino Y, Ozeki M, et al.: Pharmacological studies of FUT-175, Nafamostat Mesilate. Inhibition of protease activity in in vitro and in vivo experiments. Jpn J Pharmacol 35:203-227, 1984
20. Rachmilewitz D: On behalf of an international study group (Israel). Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomized trial. Br Med J 298:82-86, 1989
21. Matts SGF: The value of rectal biopsy in the diagnosis of ulcerative colitis. Quart J Med 393-400, 1961
22. Obayashi T, Tamura H, Tanaka S, et al.: Removal of limulus test interfering factors in blood samples with perchloric acid and the improvement of the specificity of the limulus test by fractionating amebocyte lysate. Prog Clin Biol Res 231:357-369, 1987
23. Shimoyama T, Sawada K, Hiwatashi N, et al.: Safety and efficacy of granulocyte and monocyte adsorption apheresis in patients with active ulcerative colitis: A multicenter study. J Clin Apheresis 16:1-9, 2001
24. Hanai H, Watanabe F, Saniabadi A, et al.: Therapeutic efficacy of granulocyte and monocyte adsorption apheresis in severe active ulcerative colitis. Dig Dis Sci 47:2349-2353, 2002
25. Hanai H, Watanabe F, Takeuchi K, et al.: Leukocyte adsorptive apheresis for the treatment of active ulcerative colitis: a prospective, uncontrolled, pilot study. Clin Gastroenterol Hepatol 1:28-35, 2003
26. Kosaka T, Sawada K, Ohnishi K, et al.: Effect of leukocytapheresis therapy using a leukocyte removal filter in Crohn's disease. Intern Med 38:102-111, 1999
27. Hidaka T, Suzuki K, Matsuki Y, et al.: Filtration leukocytapheresis therapy in rheumatoid arthritis: A randomized, double-blind, placebo-controlled trial. Arth Rheum 42:431-137, 1999
28. Fujimori J, Yoshino S: Improvement in rheumatoid arthritis following application of a granulotrap column, G-1. Rheumatol Int 15:175-180, 1996
29. Ohara M, Saniabadi AR, Kokuma S, et al.: Granulocytapheresis in the treatment of patients with rheumatoid arthritis. Artif Organs 21:989-994, 1997
30. Ueki Y, Yamasaki S, Kanamoto Y, et al.: Evaluation of filtration leucocytapheresis for use in the treatment of patients with rheumatoid arthritis. Rheumatology (Oxford) 39:165-171, 2000
31. Furuta T, Hotta O, Yusa N, Horigome I, Chiba S, Taguma Y: Lymphocytapheresis to treat rapidly progressive glomerulonephritis: a randomised comparison with steroid-pulse treatment. Lancet 352:203-204, 1998
32. Hidaka T, Suzuki K, Kawakami M, et al.: Dynamic changes in cytokine levels in serum and synovial fluid following filtration leukocytapheresis therapy in patients with rheumatoid arthritis. J Clin Apheresis 16:74-81, 2001
33. McCarthy DA, Rampton DS, Liu Y-C: Peripheral blood neutrophils in inflammatory bowel disease: morphological evidence of in vivo activation in active disease. Clin Exp Immunol 86:489-493, 1991
34. Meuret G, Bitzi A, Hammer B: Macrophage turnover in Crohn's disease and ulcerative colitis. Gastroenterology 74:501-503, 1978
35. Allison MC, Dhillon AP, Lewis WG, Pounder RE (eds): Inflammatory Bowel Disease. London, Mosby, 1998, pp 91-95
36. Tibble JA, Sigthorsson G, Bridger D, Fagerhol MK, Bjarnason I: Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease. Gastroenterology 119:15-22, 2000
37. Podolsky DK: Inflammatory bowel disease. N Engl J Med 347:417-429, 2002